{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T01:17:15Z","timestamp":1789435035816,"version":"build-2803163510"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,5]]},"DOI":"10.1016\/j.femsim.2003.12.006","type":"journal-article","created":{"date-parts":[[2004,1,16]],"date-time":"2004-01-16T10:15:36Z","timestamp":1074248136000},"page":"27-34","source":"Crossref","is-referenced-by-count":29,"title":["Anti-retroviral therapy with protease inhibitors decreases virulence enzyme expression in vivo by<i>Candida albicans<\/i>without selection of avirulent fungus strains or decreasing their anti-mycotic susceptibility"],"prefix":"10.1093","volume":"41","author":[{"given":"Flavia","family":"Bernardis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelina","family":"Tacconelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Mondello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Cataldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Arancia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Cauda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Cassone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"key":"10.1016\/j.femsim.2003.12.006-BIB1","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3109\/00365548609032326","article-title":"Fungal infections in patients with AIDS and AIDS-related complex","volume":"18","author":"Holmberg","year":"1986","journal-title":"Scand. J. Infect. Dis."},{"key":"10.1016\/j.femsim.2003.12.006-BIB2","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1056\/NEJM198408093110602","article-title":"Oral candidiasis in high risk patients as the initial manifestation of the acquired immunodeficiency syndrome","volume":"311","author":"Klein","year":"1984","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.femsim.2003.12.006-BIB3","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1146\/annurev.mi.45.100191.001155","article-title":"Putative virulence factors of Candida albicans","volume":"45","author":"Cutler","year":"1991","journal-title":"Ann. Rev. Microbiol."},{"key":"10.1016\/j.femsim.2003.12.006-BIB4","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/BF00158569","article-title":"The secretion of aspartyl proteinase, a virulence enzyme, by isolates of Candida albicans from the oral cavity of HIV-infected subjects","volume":"8","author":"Bernardis","year":"1992","journal-title":"Eur. J. Epidemiol."},{"key":"10.1016\/j.femsim.2003.12.006-BIB5","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1128\/JCM.33.10.2543-2549.1995","article-title":"Increased expression of Candida albicans secretory proteinase, a putative virulence factor in isolates from human immunodeficiency virus-positive patients","volume":"33","author":"Ollert","year":"1995","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.femsim.2003.12.006-BIB6","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1128\/JCM.37.5.1376-1380.1999","article-title":"High aspartyl proteinase production and vaginitis in human immunodeficiency virus-infected women","volume":"37","author":"Bernardis","year":"1999","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.femsim.2003.12.006-BIB7","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1086\/376536","article-title":"Differential expression of Candida albicans secreted aspartyl proteinase and phospholipase B genes in human correlates with active oral and vaginal infections","volume":"188","author":"Naglick","year":"2003","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.femsim.2003.12.006-BIB8","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1001\/jama.1997.03540260059037","article-title":"HIV-1 protease inhibitors. A review for clinicians","volume":"277","author":"Deeks","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.femsim.2003.12.006-BIB9","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection","volume":"338","author":"Palella","year":"1998","journal-title":"New Eng. J. Med."},{"key":"10.1016\/j.femsim.2003.12.006-BIB10","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S0140-6736(05)78279-9","article-title":"Effect of HAART on natural history of AIDS-relate opportunistic disorders","volume":"351","author":"Sepkowitz","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.femsim.2003.12.006-BIB11","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1097\/00002030-199714000-00010","article-title":"Change incidence of AIDS-defining illness in the era of antiretroviral therapy","volume":"11","author":"Brodt","year":"1997","journal-title":"AIDS"},{"key":"10.1016\/j.femsim.2003.12.006-BIB12","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1086\/314871","article-title":"In vitro and vivo anticandidal activity of human immunodeficiency virus protease inhibitors","volume":"180","author":"Cassone","year":"1999","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.femsim.2003.12.006-BIB13","first-page":"55","article-title":"Candida albicans secreted aspartyl proteinase","volume":"7","author":"Hube","year":"1996","journal-title":"Curr. Top. Med. Mycol."},{"key":"10.1016\/j.femsim.2003.12.006-BIB14","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1086\/314546","article-title":"Evidence that members of the secretory aspartyl proteinases gene family (SAP), in particolar SAP2, are virulence factors for Candida vaginitis","volume":"179","author":"Bernardis","year":"1999","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.femsim.2003.12.006-BIB15","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1086\/338445","article-title":"Antiretroviral therapy with protease inhibitors has an early, immune reconstitution-independent beneficial effect on Candida virulence and oral candidiasis in human immunodeficiency virus-infected subjects","volume":"185","author":"Cassone","year":"2002","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.femsim.2003.12.006-BIB16","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1086\/315437","article-title":"In vitro activity of human immunodeficiency virus protease inhibitors against Pneumocystis carinii","volume":"181","author":"Atzori","year":"2000","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.femsim.2003.12.006-BIB17","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1128\/AAC.44.5.1200-1208.2000","article-title":"Enhanced extracellular production of aspartyl proteinase, a virulence factor by Candida albicans isolates following growth in subinhibitory concentration of fluconazole","volume":"44","author":"Wu","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.femsim.2003.12.006-BIB18","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/00126334-199905010-00003","article-title":"Role of protease inhibitors in preventing recurrent oral candidosis in patients with HIV infection: a prospective case-control study","volume":"21","author":"Cauda","year":"1999","journal-title":"J. Acquir. Immun. Defic. Syndr. Hum. Retrovirol."},{"key":"10.1016\/j.femsim.2003.12.006-BIB19","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1093\/infdis\/161.6.1276","article-title":"Evidence for a role for secreted aspartate proteinase of Candida albicans in vulvovaginal candidiasis","volume":"161","author":"Bernardis","year":"1990","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.femsim.2003.12.006-BIB20","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1128\/AAC.38.7.1530","article-title":"In vitro activity of itraconazole against fluconazole-susceptible and -resistant Candida albicans isolates from oral cavities of patients infected with human immunodeficiency virus","volume":"38","author":"Barchiesi","year":"1994","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.femsim.2003.12.006-BIB21","unstructured":"[21] National Committee for Clinical Laboratory Standard (1997). Reference method for broth dilution antifungal susceptibility testing of yeasts; Approved Standard M27-A, NCCLS, Wayne, PA"},{"key":"10.1016\/j.femsim.2003.12.006-BIB22","doi-asserted-by":"crossref","first-page":"7865","DOI":"10.1093\/nar\/15.19.7865","article-title":"Resolution of DNA molecules greater than 5 megabases by contour clamped homogenous electric fields","volume":"15","author":"Vollrath","year":"1987","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.femsim.2003.12.006-BIB23","doi-asserted-by":"crossref","unstructured":"[23] Korting, H.C., Schaller, M., Eder, G., Hamm, G., Bohmer, U., Hube, B. Effects of the human immunodeficiency virus (HIV) proteinase inhibitors saquinavir and indinavir on in vitro activities of secreted aspartyl proteinases of Candida albicans isolates from HIV-infected patients Antimicrob. Agents Chemoth. Aug. 1999 2038 2042","DOI":"10.1128\/AAC.43.8.2038"},{"key":"10.1016\/j.femsim.2003.12.006-BIB24","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0966-842X(02)02330-2","article-title":"Antifungal therapy at the HAART of viral therapy","volume":"10","author":"Munro","year":"2002","journal-title":"Trends Microb. Opin."},{"key":"10.1016\/j.femsim.2003.12.006-BIB25","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/S0006-291X(02)02372-0","article-title":"Inhibition of Candida albicans secreted aspartic protease by a novel series of peptidomimetics, also active on the HIV-1 protease","volume":"297","author":"Skrbec","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.femsim.2003.12.006-BIB26","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1574-695X.2001.tb01588.x","article-title":"HIV protease inhibitors attenuate adherence of Candida albicans to epithelial cells in vitro","volume":"31","author":"Bektic","year":"2001","journal-title":"FEMS Immun. Med. Microb."},{"key":"10.1016\/j.femsim.2003.12.006-BIB27","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1099\/jmm.0.05048-0","article-title":"Effect of antimycotic agents on the activity of aspartyl proteinases secreted by Candida albicans","volume":"52","author":"Schaller","year":"2003","journal-title":"J. Med. Microb."},{"key":"10.1016\/j.femsim.2003.12.006-BIB28","doi-asserted-by":"crossref","first-page":"941","DOI":"10.2174\/0929867013372698","article-title":"Candida proteases and their inhibition: prospects for antifungal therapy","volume":"8","author":"Stewart","year":"2001","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.femsim.2003.12.006-BIB29","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1086\/315768","article-title":"In vivo virulence of Candida albicans isolates causing mucosal infections in people infected with the human immunodeficiency virus","volume":"182","author":"Taylor","year":"2000","journal-title":"J. Inf. Dis."},{"key":"10.1016\/j.femsim.2003.12.006-BIB30","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0162-3109(99)00035-1","article-title":"Human immunodeficiency virus type 1 protease inhibitor attenuates Candida albicans virulence properties in vitro","volume":"41","author":"Gruber","year":"1999","journal-title":"Immunopharmacology"}],"container-title":["FEMS Immunology &amp; Medical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/femspd\/article-pdf\/41\/1\/27\/19167005\/41-1-27.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,29]],"date-time":"2020-03-29T03:32:52Z","timestamp":1585452772000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/femspd\/article-lookup\/doi\/10.1016\/j.femsim.2003.12.006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,5]]}},"URL":"https:\/\/doi.org\/10.1016\/j.femsim.2003.12.006","relation":{},"ISSN":["0928-8244","1574-695X"],"issn-type":[{"value":"0928-8244","type":"print"},{"value":"1574-695X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,5]]}}}